Wada, Eiji
Matsumoto, Kohei
Susumu, Nao
Kato, Megumi
Hayashi, Yukiko K.
Funding for this research was provided by:
Grants-in-Aid for Scientific Research (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (20H03594)
Acceleration Program for Intractable Disease Research Utilizing Disease-specific iPS cells (17935395)
Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development (23809381)
Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (29-4, 2-5, 5-6)
Follow-up Grant 2022 from Tokyo Medical University
Follow-up Grant 2023 from Tokyo Medical University
Article History
Received: 1 September 2023
Accepted: 20 October 2023
First Online: 8 November 2023
Declarations
:
: All animal experiments were approved by the Animal Care & Use Committee of Tokyo Medical University (Approval Number: R5-050). All authors have confirmed that this study did not involve human participants or tissue.
: All authors read and approved the final manuscript for publication.
: All authors declare that they have no competing interest associated with this study.